v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Revenues:        
Total revenues $ 0 $ 81 $ 2,074 $ 2,000
Cost and expenses:        
Research and development 730 36 959 286
General and administrative 2,479 1,502 6,088 5,342
Total cost and expenses 3,209 1,538 7,047 5,628
Loss from operations (3,209) (1,457) (4,973) (3,628)
Other income, net        
Interest income 32 28 128 208
Gain from settlement of account payable     0 363
Gain from insurance recovery     1,317 0
Total other income, net 32 28 1,445 571
Net loss $ (3,177) $ (1,429) $ (3,528) $ (3,057)
Net loss per share:        
Net loss per share - Basic $ (0.76) $ (0.56) $ (1.11) $ (1.21)
Net loss per share - Diluted $ (0.76) $ (0.56) $ (1.11) $ (1.21)
Weighted average shares used in calculating:        
Basic shares 4,205 2,556 3,181 2,518
Diluted shares 4,205 2,556 3,181 2,518
Other comprehensive loss:        
Net loss $ (3,177) $ (1,429) $ (3,528) $ (3,057)
Other comprehensive loss:        
Foreign currency translation adjustment loss     0 (6)
Comprehensive loss     (3,528) (3,063)
Revenue from license agreement        
Revenues:        
Total revenues     1,000 1,750
Revenue from purchase agreement        
Revenues:        
Total revenues     800 0
Revenue from option agreement        
Revenues:        
Total revenues $ 0 $ 81 $ 274 $ 250